Dr. Pablo Gurman, MD, MSM, received his MD from Buenos Aires University School of Medicine and a master’s degree in management from Babson College. His experience spans 15 years of experience in R&D in the biotech and the pharmaceutical industry, as well as more than 15 years of R&D in microsystems and nanotechnology working at MIT, The University of Texas at Dallas and Argonne National Laboratory (Artificial Retina Program). His primary interests include drug development, medical device development with focus on microsystems and nanotechnology, biotechnology and public health.Dr. Yitzhak Rosen, MD, is a graduate of Tel Aviv University of Medicine. He is a practicing physician. Dr. Rosen was affiliated with the Cardiology Department at SUNY Downstate Medical Center, New York and served as a visiting research scientist at the Institute for Soldier Nanotechnologies at MIT. Currently, he is the president and CEO of Superior NanoBioSystems LLC, a biomedical company. Dr. Rosen has also served as a medical officer and physician in militarily active areas with the Israel Defense Forces (IDF). He completed his medical internship at Rabin Medical Center and has worked at the Oncology Institutes of both Rabin and Sheba Medical Centers in Israel. Notably, he invented a microfluidic chip platform, funded by DARPA, for rapid blood typing and cross-matching in mass casualty situations, in collaboration with the MEMS and Nanotechnology Exchange. Additionally, he has developed several medical ultrasound technologies.Noel M. Elman, PhD, is the CEO and founder of GearJump Technologies, LLC, a company focused on creating biotechnological solutions for public health. He is also a faculty member at the Buenos Aires Institute of Technology. Previously, Dr. Elman worked at Draper Laboratory, an MIT-affiliated and DoD-supported R&D center, where he was a distinguished member of the technical staff. Before that, he served as a research scientist and principal investigator at the Institute for Soldier Nanotechnologies at MIT, leading a translational research group dedicated to developing biotech, biomedical, and public health technologies. Dr. Elman’s research and development focus is on rapid translation from idea conceptualization to product realization. He holds bachelor’s and master’s degrees in electrical engineering from Cornell University and a PhD in physical electronics from Tel Aviv University. Additionally, he completed postdoctoral studies at MIT, where he researched various micro- and nanodevices for therapeutics and diagnostics.

• Chapter 1- IntroductionPablo Gurman, Yitzhak Rosen, and Noel M. ElmanChapter 2- Dancing with the FDA: Managing ExpectationsRaymond VennareChapter 3- New Drug ApplicationHarvey M. Arbit and Wrenda TeepleChapter 4- Basics of Generic Drug RegulationGiridhar Prasad and Anurag PatelChapter 5- Introduction to Medical Device RegulationAnurag PatelChapter 6- FDA and Regulation of BiologicsOliver V. CácanantaChapter 7- Combination ProductsEvan B. SiegelChapter 8- FDA Expedited PathwaysOliver V. CácanantaChapter 9- Investigator-Initiated Sponsored ResearchHarvey M. Arbit and Wrenda TeepleChapter 10- Medical Countermeasures for Public Health Emergency Preparedness and Response in The United States: A Regulatory PerspectiveAngela Bellos, Jack Russell, and Doris Snow

Dr. Pablo Gurman, MD, MSM, received his MD from Buenos Aires University School of Medicine and a master’s degree in management from Babson College. His experience spans 15 years of experience in R&D in the biotech and the pharmaceutical industry, as well as more than 15 years of R&D in microsystems and nanotechnology working at MIT, The University of Texas at Dallas and Argonne National Laboratory (Artificial Retina Program). His primary interests include drug development, medical device development with focus on microsystems and nanotechnology, biotechnology and public health.Dr. Yitzhak Rosen, MD, is a graduate of Tel Aviv University of Medicine. He is a practicing physician. Dr. Rosen was affiliated with the Cardiology Department at SUNY Downstate Medical Center, New York and served as a visiting research scientist at the Institute for Soldier Nanotechnologies at MIT. Currently, he is the president and CEO of Superior NanoBioSystems LLC, a biomedical company. Dr. Rosen has also served as a medical officer and physician in militarily active areas with the Israel Defense Forces (IDF). He completed his medical internship at Rabin Medical Center and has worked at the Oncology Institutes of both Rabin and Sheba Medical Centers in Israel. Notably, he invented a microfluidic chip platform, funded by DARPA, for rapid blood typing and cross-matching in mass casualty situations, in collaboration with the MEMS and Nanotechnology Exchange. Additionally, he has developed several medical ultrasound technologies.Noel M. Elman, PhD, is the CEO and founder of GearJump Technologies, LLC, a company focused on creating biotechnological solutions for public health. He is also a faculty member at the Buenos Aires Institute of Technology. Previously, Dr. Elman worked at Draper Laboratory, an MIT-affiliated and DoD-supported R&D center, where he was a distinguished member of the technical staff. Before that, he served as a research scientist and principal investigator at the Institute for Soldier Nanotechnologies at MIT, leading a translational research group dedicated to developing biotech, biomedical, and public health technologies. Dr. Elman’s research and development focus is on rapid translation from idea conceptualization to product realization. He holds bachelor’s and master’s degrees in electrical engineering from Cornell University and a PhD in physical electronics from Tel Aviv University. Additionally, he completed postdoctoral studies at MIT, where he researched various micro- and nanodevices for therapeutics and diagnostics.

• Chapter 1- IntroductionPablo Gurman, Yitzhak Rosen, and Noel M. ElmanChapter 2- Dancing with the FDA: Managing ExpectationsRaymond VennareChapter 3- New Drug ApplicationHarvey M. Arbit and Wrenda TeepleChapter 4- Basics of Generic Drug RegulationGiridhar Prasad and Anurag PatelChapter 5- Introduction to Medical Device RegulationAnurag PatelChapter 6- FDA and Regulation of BiologicsOliver V. CácanantaChapter 7- Combination ProductsEvan B. SiegelChapter 8- FDA Expedited PathwaysOliver V. CácanantaChapter 9- Investigator-Initiated Sponsored ResearchHarvey M. Arbit and Wrenda TeepleChapter 10- Medical Countermeasures for Public Health Emergency Preparedness and Response in The United States: A Regulatory PerspectiveAngela Bellos, Jack Russell, and Doris Snow

Dr. Pablo Gurman, MD, MSM, received his MD from Buenos Aires University School of Medicine and a master’s degree in management from Babson College. His experience spans 15 years of experience in R&D in the biotech and the pharmaceutical industry, as well as more than 15 years of R&D in microsystems and nanotechnology working at MIT, The University of Texas at Dallas and Argonne National Laboratory (Artificial Retina Program). His primary interests include drug development, medical device development with focus on microsystems and nanotechnology, biotechnology and public health.Dr. Yitzhak Rosen, MD, is a graduate of Tel Aviv University of Medicine. He is a practicing physician. Dr. Rosen was affiliated with the Cardiology Department at SUNY Downstate Medical Center, New York and served as a visiting research scientist at the Institute for Soldier Nanotechnologies at MIT. Currently, he is the president and CEO of Superior NanoBioSystems LLC, a biomedical company. Dr. Rosen has also served as a medical officer and physician in militarily active areas with the Israel Defense Forces (IDF). He completed his medical internship at Rabin Medical Center and has worked at the Oncology Institutes of both Rabin and Sheba Medical Centers in Israel. Notably, he invented a microfluidic chip platform, funded by DARPA, for rapid blood typing and cross-matching in mass casualty situations, in collaboration with the MEMS and Nanotechnology Exchange. Additionally, he has developed several medical ultrasound technologies.Noel M. Elman, PhD, is the CEO and founder of GearJump Technologies, LLC, a company focused on creating biotechnological solutions for public health. He is also a faculty member at the Buenos Aires Institute of Technology. Previously, Dr. Elman worked at Draper Laboratory, an MIT-affiliated and DoD-supported R&D center, where he was a distinguished member of the technical staff. Before that, he served as a research scientist and principal investigator at the Institute for Soldier Nanotechnologies at MIT, leading a translational research group dedicated to developing biotech, biomedical, and public health technologies. Dr. Elman’s research and development focus is on rapid translation from idea conceptualization to product realization. He holds bachelor’s and master’s degrees in electrical engineering from Cornell University and a PhD in physical electronics from Tel Aviv University. Additionally, he completed postdoctoral studies at MIT, where he researched various micro- and nanodevices for therapeutics and diagnostics.

• Chapter 1- IntroductionPablo Gurman, Yitzhak Rosen, and Noel M. ElmanChapter 2- Dancing with the FDA: Managing ExpectationsRaymond VennareChapter 3- New Drug ApplicationHarvey M. Arbit and Wrenda TeepleChapter 4- Basics of Generic Drug RegulationGiridhar Prasad and Anurag PatelChapter 5- Introduction to Medical Device RegulationAnurag PatelChapter 6- FDA and Regulation of BiologicsOliver V. CácanantaChapter 7- Combination ProductsEvan B. SiegelChapter 8- FDA Expedited PathwaysOliver V. CácanantaChapter 9- Investigator-Initiated Sponsored ResearchHarvey M. Arbit and Wrenda TeepleChapter 10- Medical Countermeasures for Public Health Emergency Preparedness and Response in The United States: A Regulatory PerspectiveAngela Bellos, Jack Russell, and Doris Snow